These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2758731)

  • 1. Effects of age on the serum concentration of alpha 1-acid glycoprotein and the binding of lidocaine in pediatric patients.
    Lerman J; Strong HA; LeDez KM; Swartz J; Rieder MJ; Burrows FA
    Clin Pharmacol Ther; 1989 Aug; 46(2):219-25. PubMed ID: 2758731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alpha 1-acid glycoprotein and the binding of lidocaine in children with congenital heart disease.
    Burrows FA; Lerman J; LeDez KM; Strong HA
    Can J Anaesth; 1990 Nov; 37(8):883-8. PubMed ID: 1701361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alpha 1-acid glycoprotein and serum binding of drugs in healthy and diseased dogs.
    Belpaire FM; De Rick A; Dello C; Fraeyman N; Bogaert MG
    J Vet Pharmacol Ther; 1987 Mar; 10(1):43-8. PubMed ID: 3586122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transport of propranolol and lidocaine through the rat blood-brain barrier. Primary role of globulin-bound drug.
    Pardridge WM; Sakiyama R; Fierer G
    J Clin Invest; 1983 Apr; 71(4):900-8. PubMed ID: 6833493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of lidocaine in children with congenital heart disease.
    Burrows FA; Lerman J; LeDez KM; Strong HA
    Can J Anaesth; 1991 Mar; 38(2):196-200. PubMed ID: 2021989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein binding of phenytoin and lidocaine in pediatric patients with type I diabetes mellitus.
    Kearns GL; Kemp SF; Turley CP; Nelson DL
    Dev Pharmacol Ther; 1988; 11(1):14-23. PubMed ID: 3383718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severity of cirrhosis and the relationship of alpha 1-acid glycoprotein concentration to plasma protein binding of lidocaine.
    Barry M; Keeling PW; Weir D; Feely J
    Clin Pharmacol Ther; 1990 Mar; 47(3):366-70. PubMed ID: 2311337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methadone binding to orosomucoid (alpha 1-acid glycoprotein): determinant of free fraction in plasma.
    Romach MK; Piafsky KM; Abel JG; Khouw V; Sellers EM
    Clin Pharmacol Ther; 1981 Feb; 29(2):211-7. PubMed ID: 7193106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of lidocaine interactions with serum proteins using high-performance affinity chromatography.
    Soman S; Yoo MJ; Jang YJ; Hage DS
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Mar; 878(7-8):705-8. PubMed ID: 20138813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Displacement of lidocaine from serum alpha 1-acid glycoprotein binding sites by basic drugs.
    Goolkasian DL; Slaughter RL; Edwards DJ; Lalka D
    Eur J Clin Pharmacol; 1983; 25(3):413-7. PubMed ID: 6628530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methodologic factors influencing plasma binding of alpha-1-acid glycoprotein-bound and albumin-bound drugs.
    Morse DS; Abernethy DR; Greenblatt DJ
    Int J Clin Pharmacol Ther Toxicol; 1985 Oct; 23(10):535-9. PubMed ID: 3934087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. alpha 1-Acid glycoprotein and plasma lidocaine binding.
    Shand DG
    Clin Pharmacokinet; 1984 Jan; 9 Suppl 1():27-31. PubMed ID: 6705424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in plasma drug binding and alpha 1-acid glycoprotein in mother and newborn infant.
    Wood M; Wood AJ
    Clin Pharmacol Ther; 1981 Apr; 29(4):522-6. PubMed ID: 7471620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding of aprindine and moxaprindine to human serum, alpha 1-acid glycoprotein and serum of healthy and diseased humans.
    Teirlynck O; Belpaire FM; Andreasen F
    Eur J Clin Pharmacol; 1982; 21(5):427-31. PubMed ID: 7075647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of serum protein binding on the entry of lidocaine into brain and cerebrospinal fluid in dogs.
    Marathe PH; Shen DD; Artru AA; Bowdle TA
    Anesthesiology; 1991 Nov; 75(5):804-12. PubMed ID: 1952206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors influencing serum protein binding of lidocaine in humans.
    McNamara PJ; Slaughter RL; Pieper JA; Wyman MG; Lalka D
    Anesth Analg; 1981 Jun; 60(6):395-400. PubMed ID: 6165258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of electroconvulsive therapy on serum concentration of alpha-1-acid glycoprotein.
    DeVane CL; Lim C; Carson SW; Tingle D; Hackett L; Ware MR
    Biol Psychiatry; 1991 Jul; 30(2):116-20. PubMed ID: 1912103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lidocaine plasma protein binding.
    Routledge PA; Barchowsky A; Bjornsson TD; Kitchell BB; Shand DG
    Clin Pharmacol Ther; 1980 Mar; 27(3):347-51. PubMed ID: 7357791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of inflammation on serum concentration, molecular heterogeneity and drug binding properties of canine alpha-1-acid glycoprotein.
    Dello CP; Belpaire FM; De Rick A; Fraeyman NH
    J Vet Pharmacol Ther; 1988 Mar; 11(1):71-6. PubMed ID: 3379666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of effect of treatment with human recombinant-tumour necrosis factor (HrTNF) on the binding of quinidine to alpha 1-acid glycoprotein (AGP).
    Barnett JA; Brenner DE; Creaven PJ; Lalka D
    Br J Clin Pharmacol; 1989 Feb; 27(2):257-61. PubMed ID: 2713218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.